Oxford Gene Technology (OGT) has introduced the high resolution Cytosure Duchenne Muscular Dystrophy (DMD) array.
The Cytosure DMD array features a 4x44k format and dense probe coverage of the DMD gene region.
It increases confidence when detecting deletions and duplications within the DMD gene.
OGT's bioinformatics expertise, together with extensive input from Emory Genetics Laboratory and the array manufacturing precision of Agilent Technologies, ensures confidence in quality and performance.
The Cytosure DMD array has undergone a process of empirical testing and optimisation to provide probe sets of high sensitivity and specificity.
Average exon probe spacing of 10bp (106bp within introns) ensures excellent resolution.
As a result, the entire DMD gene is covered on a single 44,000 feature array, which enables four full arrays per slide, maximising cost-efficiency by reducing the cost per sample.
The Cytosure Genomic DNA labelling kit and the Cytosure Interpret Software simplify the manual processing and analysis of the Cytosure DMD array.
For higher-throughput applications, the Cytosure DMD array is compatible with Scigene workflow automation products (now distributed in Europe by OGT).
